HIV Screening via Fourth-Generation Immunoassay or Nucleic Acid Amplification Test in the United States: A Cost-Effectiveness Analysis

BACKGROUND: At least 10% of the 56,000 annual new HIV infections in the United States are caused by individuals with acute HIV infection (AHI). It unknown whether the health benefits and costs of routine nucleic acid amplification testing (NAAT) are justified, given the availability of newer fourth-...

Descripción completa

Detalles Bibliográficos
Autor principal: Long, Elisa F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218000/
https://www.ncbi.nlm.nih.gov/pubmed/22110698
http://dx.doi.org/10.1371/journal.pone.0027625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218000/
https://www.ncbi.nlm.nih.gov/pubmed/22110698
http://dx.doi.org/10.1371/journal.pone.0027625

Ejemplares similares